Literature DB >> 8020908

Imaging diagnosis of small hepatocellular carcinoma.

K Ikeda1, S Saitoh, I Koida, A Tsubota, Y Arase, K Chayama, H Kumada.   

Abstract

To elucidate the detectability of small hepatocellular carcinoma by various imaging modalities, we performed digital subtraction angiography, computed tomographic arterioportography and carbon dioxide-enhanced ultrasonography. Of 76 patients with a small hepatocellular carcinoma of 2 cm or less in maximum diameter, 61 underwent digital subtraction angiography, computed tomographic arterioportography and enhanced ultrasonography at the same time. Concerning the 61 patients undergoing all the procedures, the characteristics of hepatocellular carcinoma were found in 57.4% (35 of 61) by digital subtraction angiography, 75.4% (46 of 61) by computed tomographic arterioportography and 72.1% (44 of 61) by enhanced ultrasonography. Among them, four hepatocellular carcinomas were detected only by enhanced ultrasonography, three were diagnosed only by computed tomographic arterioportography and two were diagnosed by both of them. Except for six hemangioma nodules that were easily diagnosed only with angiography, four of 55 benign hepatic nodules (7.3%) showed false-positive findings suggestive of hepatocellular carcinoma with either computed tomographic arterioportography or enhanced ultrasonography. In conclusion, computed tomographic arterioportography and enhanced ultrasonography could complementarily detect a small hepatocellular carcinoma more sensitively than digital subtraction angiography.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020908     DOI: 10.1016/0270-9139(94)90137-6

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C.

Authors:  Richard K Sterling; Elizabeth C Wright; Timothy R Morgan; Leonard B Seeff; John C Hoefs; Adrian M Di Bisceglie; Jules L Dienstag; Anna S Lok
Journal:  Am J Gastroenterol       Date:  2011-09-20       Impact factor: 10.864

2.  Usefulness of ED036 kit for measuring serum PIVKA-II levels in small hepatocellular carcinoma.

Authors:  R Kuromatsu; M Tanaka; Y Shimauchi; M Shimada; K Tanikawa; K Watanabe; T Yokoo
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

3.  Value of new contrast harmonic technique for detecting tumor vascularity in hepatocellular carcinoma: Preliminary results.

Authors:  Yan Ling Wen; Masatoshi Kudo; Yasunori Minami; Hobyung Chung; Yoichiro Suetomi; Hirokazu Onda; Masayuki Kitano; Toshihiko Kawasaki; Kiyoshi Maekawa
Journal:  J Med Ultrason (2001)       Date:  2003-06       Impact factor: 1.314

Review 4.  Guide for diagnosis and treatment of hepatocellular carcinoma.

Authors:  Magdy Hamed Attwa; Shahira Aly El-Etreby
Journal:  World J Hepatol       Date:  2015-06-28

5.  Outcome of small liver nodules detected by computed tomographic angiography in patients with hepatocellular carcinoma.

Authors:  Hideki Ohnishi; Kohsaku Sakaguchi; Kazuhiro Nouso; Yoshiyuki Kobayashi; Shinichiro Nakamura; Hironori Tanaka; Yasuhiro Miyake; Bon Shoji; Shouta Iwadou; Yasushi Shiratori
Journal:  Hepatol Int       Date:  2010-07-25       Impact factor: 6.047

Review 6.  Diagnosis of hepatocellular carcinoma.

Authors:  Asmaa I Gomaa; Shahid A Khan; Edward L S Leen; Imam Waked; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

7.  Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C.

Authors:  J Raedle; W K Roth; G Oremek; W F Caspary; S Zeuzem
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.